KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cognex (CGNX) Research & Development (2016 - 2025)

Historic Research & Development for Cognex (CGNX) over the last 17 years, with Q4 2025 value amounting to $36.1 million.

  • Cognex's Research & Development rose 1082.43% to $36.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $139.0 million, marking a year-over-year decrease of 60.44%. This contributed to the annual value of $139.0 million for FY2025, which is 60.44% down from last year.
  • Latest data reveals that Cognex reported Research & Development of $36.1 million as of Q4 2025, which was up 1082.43% from $35.1 million recorded in Q3 2025.
  • Over the past 5 years, Cognex's Research & Development peaked at $38.5 million during Q2 2023, and registered a low of $31.3 million during Q3 2021.
  • Its 5-year average for Research & Development is $34.7 million, with a median of $34.7 million in 2023.
  • Its Research & Development has fluctuated over the past 5 years, first surged by 1400.79% in 2021, then tumbled by 657.35% in 2023.
  • Cognex's Research & Development (Quarter) stood at $35.5 million in 2021, then increased by 4.64% to $37.1 million in 2022, then dropped by 6.57% to $34.7 million in 2023, then dropped by 6.21% to $32.5 million in 2024, then increased by 10.82% to $36.1 million in 2025.
  • Its last three reported values are $36.1 million in Q4 2025, $35.1 million for Q3 2025, and $33.1 million during Q2 2025.